All Videos Channels
  1. Soligenix, Inc. (Nasdaq: SNGX) CEO Christopher Schaber - Interview - RICH TV LIVE

    Soligenix, Inc. (Nasdaq: SNGX) CEO Christopher Schaber - Interview - RICH TV LIVE

    15
    2
    63
  2. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  3. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    4
  4. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    20
  5. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    16
  6. September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    28
  7. Soligenix: Illuminating the Future of Rare Disease Therapies

    Soligenix: Illuminating the Future of Rare Disease Therapies

    16
  8. May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    16